Annual Recurring Revenue (ARR) guidance for year-end 2026
Company: Nebius
The claim, verbatim
ARR guidance of $7 billion to $9 billion by year-end 2026
Source (primary)
Should You Grab Nebius In Anticipation of Full Capacity Pricing? - Yahoo Finance (-, news_article)
View cached copy (2026-09-10)Live source ↗Archive.org ↗
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The article states that ARR guidance of $7B to $9B by year-end 2026 was reaffirmed.
Confirmed in the source:
- Nebius's ARR guidance is $7 billion to $9 billion by year-end 2026
What we did: Read our cached copy of the publisher (https://finance.yahoo.com/markets/stocks/articles/grab-nebius-anticipation-full-capacity-143330716.html) in full (14,091 characters, retrieved September 10, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Should You Grab Nebius In Anticipation of Full Capacity Pricing? - Yahoo Finance
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”
confirms Should You Grab Nebius In Anticipation of Full Capacity Pricing? - 247wallst.com
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”
confirms Should You Grab Nebius In Anticipation of Full Capacity Pricing? - 24/7 Wall St.
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”